Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 3 8Phase 2 5Phase 4 2Phase 1 2

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 1331Breast Neoplasms 688Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 437Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 366Lymphoma, Non-Hodgkin 356Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 267Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 254Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Hodgkin Disease 193Carcinoma, Renal Cell 193Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Glioma 172Burkitt Lymphoma 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Colitis, Ulcerative × Clear all
NCT02365480 2021-08-03

Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission

National Cancer Institute (NCI)

Phase 1 Completed
18 enrolled 13 charts

Colitis, Ulcerative

NCT01759056 2014-03-05

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Avaxia Biologics, Incorporated

Phase 1 Completed
33 enrolled

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡